Refine
Document Type
- Article (12)
Keywords
- Clinical Neurology (3)
- Neurology (3)
- Anesthesiology and Pain Medicine (1)
- Hematology (1)
- Immunology and Allergy (1)
- Infectious Diseases (1)
- Microbiology (1)
Institute
- Medizinische Fakultät (12)
- Universitätsklinikum (9)
- Lehrstuhl für Medizinische Psychologie und Soziologie (7)
- Fakultät für Angewandte Informatik (4)
- Institut für Informatik (4)
- Institut für Mathematik (4)
- Lehrstuhl für Datenmanagement und Clinical Decision Support (4)
- Lehrstuhl für Frauenheilkunde (4)
- Lehrstuhl für Rechnerorientierte Statistik und Datenanalyse (4)
- Mathematisch-Naturwissenschaftlich-Technische Fakultät (4)
Erste Ergebnisse der WAVES-Studie bestätigen die Annahme einer deutlich höheren Zufriedenheit von Patient:innen im Zusammenhang mit der Mitteilung der Erstdiagnose Brustkrebs, wenn sich die Ärztin / der Arzt Zeit dafür nahm, im Idealfall mindestens 30 Minuten. Der Bedarf an verbesserter Kommunikation hinsichtlich eines angemessenen Zeitrahmens für die Diagnoseübermittlung bei Brustkrebs-Erkrankten wird damit klar aufgezeigt. Diese Daten bieten die Grundlage für eine mögliche Umstrukturierung in der Behandlung Brustkrebs-Erkrankter, die bisher in der aktuellen Vergütungsstruktur nicht abgebildet ist. Die Studie rekrutiert weiterhin.
Aim of the study: The "WAVES" study (Widening Aims and giving patients a Voice for Expanded Structures in breast cancer care developed jointly by patients and physicians) aims to illuminate current breast cancer care structures with special focus on physician-patient-communication.
Methods: The study is conducted within and funded by the BZKF (Bavarian Center for Cancer Research). Here, we present the results of the first preplanned analysis of the survey designed together with patients and patient advocates with the aim of adequately reflecting patients concerns. It is based on the evaluation of the first 1.000 patients who participated between 05/2022 and 08/2023, focusing on the duration of the first diagnosis consultation.
Results: The participants were between 23 and 89 years old (mean: 59.18 years). There was a significant association between longer initial consultation duration and higher patient satisfaction (p < 0.001). When the first consultation lasted 30 minutes or more, patients stated more frequently that they felt better informed (p < 0.001) and had fully or substantially understood the content (p < 0.001).
Conclusion: These results demonstrate a significantly higher satisfaction and better preparation of patients with initial breast cancer diagnosis if physicians’ communication lasted 30 minutes or more. Therefore the WAVES study clearly demonstrates the need for improved communication structures in terms of an appropriate time frame for breast cancer patients, which is not reflected in the current reimbursement structures.
Background: Pulmonary metastasectomy (PM) is the most frequently performed local ablative therapy for leiomyosarcoma (LMS), synovial sarcoma (SyS), and undifferentiated pleomorphic sarcoma (UPS). This study aimed to assess surgical feasibility, outcome, and clinical prognostic factors, as well as the value of a peri-interventional systemic therapy.
Methods: This multicenter retrospective study enrolled 77 patients with LMS, SyS, or UPS who underwent first-time complete resection of isolated lung metastases between 2009 and 2021. Disease-free survival (DFS), overall survival (OS), and clinical prognostic factors were analyzed.
Results: After the first PM, the median DFS was 7.4 months, and the median OS was 58.7 months. A maximal lesion diameter greater than 2 cm was associated with reduced DFS in both the univariable (hazard ratio [HR], 2.29; p = 0.006) and multivariable (HR, 2.60; p = 0.005) analyses. The univariable analysis identified a maximal lesion diameter greater than 2 cm as an adverse prognostic factor for OS (HR, 5.6; p < 0.001), whereas a treatment-free interval longer than 12 months was associated with improved OS (HR, 0.42; p = 0.032). The addition of systemic therapy was associated with a trend toward improved DFS for patients with lesions larger than 2 cm (HR, 0.29; p = 0.063). Severe postoperative complications (grade ≥IIIa) occurred in 2 % of the patients.
Conclusion: The size of resected lung metastases might be a more relevant prognostic factor than their number for patients with LMS, SyS, or UPS. For patients with lung metastases larger than 2 cm in maximal diameter, additional systemic therapy may be warranted.
